Muscarinic Receptor Activation Preferentially Inhibits Rebound in Vulnerable Dopaminergic Neurons. [PDF]
Beaver ML, Evans RC.
europepmc +1 more source
Socioeconomic Status Related to Prescription of Triple Therapy and Anticholinergic Monotherapy in Patients with Chronic Obstructive Pulmonary Disease (COPD) in Sweden - A Retrospective National Registry Study. [PDF]
Larsson K +4 more
europepmc +1 more source
Treatment Patterns and Triple Therapy Utilization in Chinese Patients with Chronic Obstructive Pulmonary Disease: An Analysis of Real-World Data from the Yinzhou Database. [PDF]
Chen Y +11 more
europepmc +1 more source
Voltage-Gated and Chemogenetic Modulation of Calcium Signaling in Oligodendrocyte Development and Synaptic Integration. [PDF]
Cheli VT, Paez PM.
europepmc +1 more source
Use of long-acting muscarinic antagonists for severe asthma: insights from clinicians in the SHARP network. [PDF]
Marcon A +11 more
europepmc +1 more source
The impact of muscarinic and mGlu receptors modulators on MK-801-induced impairments in NO-dependent processes both in vitro and in vivo. [PDF]
Burnat G +3 more
europepmc +1 more source
Editorial Expression of Concern for Poon et al., Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis. [PDF]
europepmc +1 more source

